Pulmonx: 3 Key Takeaways for Long-Term Investors
All You Need to Know About Pulmonx (LUNG) Rating Upgrade to Buy
Pulmonx to Participate in Upcoming Investor Conferences
Stifel Maintains Buy on Pulmonx, Raises Price Target to $4
Pulmonx (LUNG) Q3 2026 Earnings Call Transcript
What Pulmonx (LUNG) Said on Its Q3 Earnings Call
Pulmonx Corp (NASDAQ:LUNG) Q3 2026 Earnings Beat and Narrower Loss Drive After-Hours Surge
Pulmonx Reports Third Quarter 2026 Financial Results
Pulmonx Corporation (LUNG) Q3 2026 Earnings Call Transcript
Pulmonx Q3 2026 Earnings Call Transcript
Pulmonx Q3 EPS $(0.19) Beats $(0.26) Estimate, Sales $22.835M Beat $21.944M Estimate
Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.608M Est
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
Pulmonx Shares Fall Following Recent Gains
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy?
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now?
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript
Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.